“…Cases of such intraoperative complications could jeopardize patient safety, therefore a clear understanding and rapid, appropriate management by the clinician is paramount. Nevertheless, it has been concluded that an application of irreversible PEFs directly to cardiac tissue both endocardially and epicardially in preclinical studies is safe when timed with the R-wave during sinus rhythm, and in early clinical studies regardless of timing [ 51 , 66 , 80 , 81 , 82 , 90 , 100 , 101 ]. However, as PEF is a novel technique, safety boundaries and significant safety data remain scarce for human application and further investigation is required.…”